Viewing Study NCT00748657


Ignite Creation Date: 2025-12-24 @ 7:08 PM
Ignite Modification Date: 2025-12-29 @ 6:27 PM
Study NCT ID: NCT00748657
Status: COMPLETED
Last Update Posted: 2019-07-23
First Post: 2008-09-05
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Bevacizumab in Treating Patients With Recurrent Sex Cord-Stromal Tumors of the Ovary
Sponsor: National Cancer Institute (NCI)
Organization:

Organization Data

Organization:
Class: NIH
Study ID: NCI-2009-00611
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: NIH
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None OTHER View